Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...

David V. Elkins currently works at Tapestry, Inc., as Independent Director from 2024 and Bristol Myers Squibb Co., as Chief Financial Officer & Executive Vice President. Mr. Elkins also formerly ...